Abiopharma

News list

Walbert Keli 🟢 acquired 3.4K shares (1 derivative) of SPRUCE BIOSCIENCES, INC. (SPRB) at $88.41 Transaction Date: Dec 11, 2025 | Filing ID: 000007

Full text

News bot Dec. 15, 2025, 11:47 p.m.
🔍 Walbert Keli (Executive)

Company: SPRUCE BIOSCIENCES, INC. (SPRB)

Report Date: 2025-12-11
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 3,400
Detailed Transactions and Holdings:
- Acquired 3,400 shares of Stock Option (Right to Buy) at $88.41 per share (Derivative)
  Date: 2025-12-11 | Code: A | Expires: 2035-12-10 | equity_swap_involved: 0 | shares_owned_after: 3,400.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The option vests in equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the date of grant, subject to the Reporting Person's Continuous Service (as defined in the 2020 Equity Incentive Plan (the "Plan") through each such vesting date and will vest in full upon a Change in Control (as defined in the Plan).